Department of Radiation Oncology II ( Lanzhou Heavy Ion Center)

Department of Radiation Oncology II, Lanzhou Heavy Ion Center, Gansu Wuwei Cancer Hospital

(Guarding Women's Dignity with Cutting-Edge Technology, Prolonging Life with Precision Radiotherapy)

I. Department Overview and Positioning

Since its official establishment on December 31, 2024, Department of Radiation Oncology II has served as a specialized unit for gynecological oncology radiotherapy. Focused on the radiotherapy of gynecological tumors, the department is equipped with advanced radiation therapy equipment and a professional medical team to provide precise, standardized, and personalized comprehensive treatment for patients with gynecological tumors. It actively conducts basic and clinical research related to gynecological tumor radiotherapy and undertakes multiple scientific projects. Simultaneously, as a training and internship base, the department cultivates talent for the industry. Aiming to be patient-centered and technology-supported, it is dedicated to improving the cure rate and quality of life for gynecological cancer patients, delivering high-quality, efficient, and humane medical services.

II. Talent Team and Discipline Structure

• Team Size:The department currently has 12 medical staff members, including 4 physicians and 8 nurses. Among them, one holds a senior professional title and three hold intermediate-level titles.

• Core Expert:The Department Director, Chief Physician Zhao Fengju, has over 30 years of experience in radiation oncology. A renowned oncology specialist in Northwest China, she serves as the Chairwoman of the Gansu Anti-Cancer Association Brachytherapy Committee and Vice Chairwoman of the Northwest Gynecological Oncology and Brachytherapy Committee. She specializes in comprehensive treatments for gynecological tumors, including radiotherapy, chemotherapy, immunotherapy, and targeted therapy. She has pioneered techniques such as carbon ion radiotherapy (CIRT), image-guided radiotherapy (IGRT) for gynecological tumors, 3D brachytherapy, interstitial implantation, and painless afterloading therapy, possessing extensive clinical experience in oncology radiochemotherapy.

• Talent Structure:The department includes three postgraduate degree holders. The talent echelon is under development, with mid-level professionals currently being cultivated.

• Nursing Team:The nursing team is proficient in standardized nursing procedures for radiotherapy related to cervical cancer, endometrial cancer, vaginal cancer, vulvar cancer, and breast cancer.

III. Scope of Services and Technical Expertise

• Primary Scope:The department primarily conducts carbon ion and photon radiotherapy, as well as brachytherapy, for various gynecological malignancies, including cervical cancer, endometrial cancer, ovarian cancer, vulvar cancer, and vaginal cancer, alongside comprehensive treatments such as chemotherapy, targeted therapy, immunotherapy, and cellular immunotherapy.

• Core Technologies/Specialties:The department employs diversified precision strategies. Photon external beam radiotherapy (e.g., IMRT/VMAT) forms the foundation, responsible for large-field irradiation and prophylactic coverage of lymphatic drainage areas, characterized by high precision and minimal damage. Intracavitary brachytherapy and interstitial implantation are critical for achieving radical cure, especially for cervical cancer, allowing precise delivery of very high doses to the tumor target while optimally protecting adjacent organs like the bladder and rectum. For tumors resistant to conventional radiotherapy or recurrent refractory cases, carbon ion radiotherapy leverages its unique physical and biological advantages to more effectively eradicate tumor cells, showing exceptional therapeutic promise. The synergistic application of these modalities enables the development of personalized optimal treatment plans for patients.

IV. Hardware Facilities and Research Platform

• Hardware Facilities:The department's equipment establishes a precise, multi-dimensional radiotherapy system for gynecological tumors: Two high-precision photon linear accelerators (Varian VitalBeam and Elekta Infinity) serve as the mainstay for conventional external beam radiotherapy, efficiently delivering large-field irradiation and accurately tracking moving targets (e.g., breast) using techniques like IMRT/VMAT and SBRT. The Varian afterloader is an indispensable core for radical radiotherapy of cancers like cervical cancer, providing a decisive "inside-out" dose boost to the primary lesion. The domestically produced carbon ion therapy system acts as a "strategic asset," specifically deployed for tackling radioresistant, refractory, or recurrent tumors adjacent to critical organs.

• Research Platform:The hospital has developed into an internationally leading research and clinical platform centered around the fully independent intellectual property-based domestic heavy ion therapy system, achieving a leap from technological follower to leader. It has set eight world-first records, including the unique "dual-center operation" model, and has treated over 2,300 patients from more than ten countries. Through more than 20 clinical studies and deep collaboration with top global institutions, the platform continuously promotes the standardization and accessibility of heavy ion technology. It has built a complete innovation ecosystem spanning basic research, precision treatment, and whole-life-cycle rehabilitation, committed to benefiting more cancer patients with this cutting-edge technology.

V. Service Philosophy and Patient Care

The department's service philosophy is: grounded in cutting-edge technology and centered on patient experience, creating a safe harbor for women's health that combines medical rigor with humanistic warmth. We deeply understand the unique physical and psychological challenges gynecological cancer diagnosis and treatment pose to women. Therefore, our care permeates the entire treatment process, committed to providing differentiated, individualized, and compassionate healthcare. The department conducts multidisciplinary discussions (MDTs) with experts from Peking University Third Hospital's Radiation Oncology Department for complex cases, ensuring patients receive treatment at nationally advanced levels.

VI. Contact Information and Patient Guide

• Location: 7th Floor, Inpatient Building 2, Lanzhou Heavy Ion Center, Gansu Wuwei Cancer Hospital.

• Outpatient Hours: Monday to Friday